 |
 |

Staphylococcus aureus BacteremiaClinical, Serologic, and Echocardiographic Findings in Patients With and Without Endocarditis
Arnold S. Bayer, MD;
Kitty Lam, MD;
Leonard Ginzton, MD;
Dean C. Norman, MD;
Chung-Yin Chiu, MS;
Joel I. Ward, MD
Arch Intern Med. 1987;147(3):457-462.
Abstract
 |  |
Seventy-two adult patients with Staphylococcus aureus bacteremia were prospectively studied clinically, serologically, and echocardiographically. Multivariate analysis identified four parameters that significantly predicted endocarditis in staphylococcemic patients at time of initial evaluation: (1) absence of a primary site of infection; (2) community acquisition of infection; (3) metastatic sequelae; and (4) valvular vegetations detected by echocardiography. Echocardiography was most predictive of endocarditis in patients with community-acquired S aureus bacteremia from an obvious primary focus. In 11 (69%) of 16 patients with endocarditis and vegetations on two-dimensional echocardiography, this technique also revealed other important findings, including ventricular dilatation, and/or underlying valvular lesions. In 18% of patients with S aureus bacteremia without stigmata of endocarditis, echocardiography provided information that led to a diagnosis of endocarditis and a subsequent change in therapy. Our findings support the routine use of two-dimensional echocardiography in all cases of community-acquired S aureus bacteremia to identify occult endocarditis in patients without classic stigmata of disease, and to provide important prognostic data in clinically apparent endocarditis.
(Arch Intern Med 1987;147:457-462)
Author Affiliations
From the Departments of Medicine (Drs Bayer, Lam, Ginzton, and Norman) and Pediatrics (Dr Ward and Mr Chiu), Harbor-UCLA Medical Center, Torrance, Calif, and the UCLA School of Medicine (Drs Bayer, Lam, Ginzton, Norman, and Ward).
Footnotes
Accepted for publication April 26, 1986.
Reprint requests to Division of Adult Infectious Diseases, Harbor/UCLA Medical Center, 1000 W Carson St, Bldg E-5, Torrance, CA 90509 (Dr Bayer).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Staphylococcus aureus: The new adventures of a legendary pathogen
REHM
Cleveland Clinic Journal of Medicine 2008;75:177-192.
ABSTRACT
| FULL TEXT
Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Baddour et al.
Circulation 2005;111:e394-e434.
ABSTRACT
| FULL TEXT
Infective endocarditis in congenital heart disease: Japanese national collaboration study
Niwa et al.
Heart 2005;91:795-800.
ABSTRACT
| FULL TEXT
Back pain and dyspnoea in a middle aged diabetic male
Postgrad. Med. J. 2000;76:243b-243.
FULL TEXT
Prospective Analysis of Staphylococcus aureus Bacteremia in Nonneutropenic Adults With Malignancy
Gopal et al.
JCO 2000;18:1110-1110.
ABSTRACT
| FULL TEXT
Diagnosis and Management of Infective Endocarditis and Its Complications
Bayer et al.
Circulation 1998;98:2936-2948.
FULL TEXT
Staphylococcus aureus Catheter-Associated Bacteremia: Minimal Effective Therapy and Unusual Infectious Complications Associated With Arterial Sheath Catheters
Malanoski et al.
Arch Intern Med 1995;155:1161-1166.
ABSTRACT
Transesophageal Echocardiography
Daniel and Mugge
NEJM 1995;332:1268-1280.
FULL TEXT
|